A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

Michael Camilleri, William Y. Chey, Emeran A. Mayer, Allison R. Northcutt, Amy Heath, George E. Dukes, David McSorley, Allen M. Mangel

Research output: Contribution to journal › Article › peer-review

250 Scopus citations

Fingerprint

Dive into the research topics of 'A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences